tiprankstipranks
Advertisement
Advertisement

OMER Stock Latest News

Buy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving Upside
RatingsBuy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving Upside
8d ago
OMER
Omeros price target lowered to $33 from $40 at H.C. Wainwright
PremiumThe Fly
Omeros price target lowered to $33 from $40 at H.C. Wainwright
8d ago
OMER
Analyst Maintains Hold on Omeros, Raises Price Target to $10.72 Despite European Regulatory Setback
PremiumRatings
Analyst Maintains Hold on Omeros, Raises Price Target to $10.72 Despite European Regulatory Setback
8d ago
OMER
Omeros announces CHMP adopts negative opinion on MAA for narsoplimab
PremiumThe Fly
Omeros announces CHMP adopts negative opinion on MAA for narsoplimab
8d ago
OMER
Omeros Plans Repurchase of Convertible Senior Notes
PremiumCompany Announcements
Omeros Plans Repurchase of Convertible Senior Notes
16d ago
8K
OMER
Omeros trading resumes
PremiumThe FlyOmeros trading resumes
22d ago
OMER
Omeros trading halted, volatility trading pause
Premium
The Fly
Omeros trading halted, volatility trading pause
22d ago
OMER
Omeros Earnings Call: YARTEMLEA Fuels a New Phase
Premium
Company Announcements
Omeros Earnings Call: YARTEMLEA Fuels a New Phase
2M ago
OMER
Omeros’ $100 Million Buyback Plan Heightens Volatility and Valuation Risk for Shareholders
PremiumCompany Announcements
Omeros’ $100 Million Buyback Plan Heightens Volatility and Valuation Risk for Shareholders
2M ago
OMER
Omeros Earnings Call: YARTEMLEA Launch Drives New Phase
PremiumCompany Announcements
Omeros Earnings Call: YARTEMLEA Launch Drives New Phase
2M ago
OMER
Omeros reports Q1 adjusted EPS (24c), consensus (28c)
PremiumThe Fly
Omeros reports Q1 adjusted EPS (24c), consensus (28c)
2M ago
OMER
Omeros options imply 10.8% move in share price post-earnings
PremiumThe Fly
Omeros options imply 10.8% move in share price post-earnings
2M ago
OMER
Kyverna Therapeutics appoints Nadia Dac as chief commercial officer
PremiumThe FlyKyverna Therapeutics appoints Nadia Dac as chief commercial officer
2M ago
KYTX
OMER
Sagimet Biosciences appoints Grauer as Chief Medical Officer
Premium
The Fly
Sagimet Biosciences appoints Grauer as Chief Medical Officer
3M ago
OMER
SGMT
Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA
Premium
The Fly
Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA
3M ago
OMER
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
PremiumCompany Announcements
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
3M ago
OMER
Closing Bell Movers: Nike slides 9% after Q3 results, soft outlook
PremiumThe Fly
Closing Bell Movers: Nike slides 9% after Q3 results, soft outlook
3M ago
RH
NKE
Omeros reports Q4 EPS $1.22, consensus 36c
PremiumThe Fly
Omeros reports Q4 EPS $1.22, consensus 36c
3M ago
OMER
Omeros Corporation (OMER) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Omeros Corporation (OMER) Q4 Earnings Cheat Sheet
4M ago
OMER
Omeros: YARTEMLEA Cash Flows Funding High-Upside OncotoX-AML Pipeline, Supporting Buy Rating and $40 Target
PremiumRatingsOmeros: YARTEMLEA Cash Flows Funding High-Upside OncotoX-AML Pipeline, Supporting Buy Rating and $40 Target
5M ago
OMER
Omeros announces completion of nonhuman primates OncotoX-AML study
Premium
The Fly
Omeros announces completion of nonhuman primates OncotoX-AML study
5M ago
OMER
Omeros announces first commercial sales of Yartemlea
Premium
The Fly
Omeros announces first commercial sales of Yartemlea
5M ago
OMER

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >